Pharma and biopharmaceutical supply chains continue to grow more complex & global. The process of sourcing active pharmaceutical ingredients (APIs) and intermediates has also become more challenging. In 2018, ISR Reports looked at how experience and capacity impact small molecule API outsourcing. Among the findings, about 25% of respondents indicated their company lacked the capacity[…]